Tesamorelin is a once-daily injectable medication that stimulates the body’s natural release of growth hormone, which may increase IGF-1 and influence
abdominal/visceral fat metabolism. While Tesamorelin is FDA-approved as Egrifta for reduction of excess abdominal fat in adults with HIV-associated lipodystrophy, it is not FDA-approved for wellness use.
